Simcere Pharmaceutical Group Limited(2096.HK) is rapidly transitioning to an innovation and R&D-driven pharmaceutical company, with a mission of “providing today’s patients with medicines of the future.” Simcere focuses on three therapeutic areas: oncology, central nervous system diseases and autoimmune diseases, with a diversified product portfolio and industry-leading capabilities. Its vigorous in-house R&D efforts and extensive R&D collaborations have made it a strategic cooperation partner with world leading pharmaceutical companies and biotechnology companies, in an effort to bring more global life science breakthroughs to patience in China. We have been continuously recognized as one of the “Top 10 Innovative Pharmaceutical Enterprises in China” and “Top 100 Pharmaceutical Manufacturing Enterprises of China ”.
Simcere Pharmaceutical Group has the ambition to develop our presence further globally, focusing on the US and Europe by continuously expanding our early discovery sites, Business Development organization, and clinical development capabilities.
As an organization, our core value is Patient First, Integrity, Collaboration and Strive for Excellence.
The Senior Finance Manager, US will be reporting to Senior Finance Director of R&D and Business Development business (based in China), acting as the bridge between head quarter and US local business in finance management front, responsible for delivering solid financial controlling support to Simcere HQ and US local business.